6-((1R)-1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-1,2,4-TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE
UNII EX5YF58MG8
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((1r)-1-(6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)ethyl)quinoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EX5YF58MG8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1151800-53-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H17N7 VQYHPUHKYSSEOB-CYBMUJFWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((1r)-1-(6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)ethyl)quinoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.